February 27, 2015 9:00 AM ET

Capital Markets

Company Overview of Burrill Biotechnology Capital Fund II, L.P.

Company Overview

Burrill Biotechnology Capital Fund II, L.P. specializes in investments in early stage through mezzanine stage. It typically invests in Series A, B, and mid-stage rounds. The fund invests in companies in the biotechnology industry. It seeks investments in North America and Europe. The fund typically invests between $500,000 and $7 million per company.

One Embarcadero Center

Suite 2700

San Francisco, CA 94111

United States

Founded in 2003





Key Executives for Burrill Biotechnology Capital Fund II, L.P.

Burrill Biotechnology Capital Fund II, L.P. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
The Leland Group, Inc. United States
Central Washington Grain Growers, Inc. United States
Cherry Tree Acquisition Corp. United States
McNally Financial Services Corporation United States
Market Edge United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Burrill Biotechnology Capital Fund II, L.P., please visit www.burrillandco.com/funds/funds_bio.html. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.